Evidence map›Paper›PMID 30371178›Full record

ReviewJournal of the American Heart Association2018

Ischemia and No Obstructive Coronary Artery Disease ( INOCA ): What Is the Risk?

Romana Herscovici, Tara Sedlak, Janet Wei, Carl J Pepine, Eileen Handberg, C Noel Bairey Merz

Abstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Electrocardiographic Predictors of Major Adverse Cardiovascular Events in Women With Suspected Ischemia and no Obstructive Coronary Artery Disease: Results of the Women's Ischemia Syndrome Evaluation.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Impact of Estrogen on Purinergic Signaling in Microvascular Disease.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA).Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Review
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Romana Herscovici1 Barbra Streisand Women's Heart Center Cedars-Sinai Smidt Heart Institute Los Angeles CA.
Tara Sedlak2 Vancouver General Hospital Vancouver British Columbia Canada.
Janet Wei1 Barbra Streisand Women's Heart Center Cedars-Sinai Smidt Heart Institute Los Angeles CA.
Carl J Pepine3 University of Florida Gainesville FL.
Eileen Handberg3 University of Florida Gainesville FL.
C Noel Bairey Merz1 Barbra Streisand Women's Heart Center Cedars-Sinai Smidt Heart Institute Los Angeles CA.

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI WANG, CHRISTINA C. · 1985 to 2011
$74.2M
UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
Cardiovascular Events in Women's Ischemia Syndrome EvaluationR03AG032631 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELSEY, SHERYL F · 2008 to 2009
$137k
NCATS NIH HHS UL1 TR000064NCRR NIH HHS M01 RR000425NIA NIH HHS R03 AG032631
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Primary PreventionSecondary PreventionAntihypertensive AgentsCoronary Artery DiseaseHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMicrovascular AnginaRiskAntihypertensive AgentsHydroxymethylglutaryl-CoA Reductase Inhibitorsischemic heart diseasemicrovascular dysfunctionrisk scores

Identifiers

PMID30371178
PMCPMC6201435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.